Security key
59935V107
Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST)
CUSIP: 59935V107
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Shares, no par value per share
- Shares outstanding
- 124,817,707
- Total 13F shares
- 20,571,334
- Share change
- +5,099,717
- Total reported value
- $137,829,226
- Put/Call ratio
- 0%
- Price per share
- $6.70
- Number of holders
- 33
- Value change
- +$33,967,631
- Number of buys
- 22
- Number of sells
- 10
Report period
Q4 2020
Institutions
33
Top holders
10
MIST full security history
Newer quarter: Q1 2021
Previous quarter: Q3 2020
Milestone Pharmaceuticals Inc. SEC filings
Milestone Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 59935V107
Recent filing periods:
Top shareholders of MIST - Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP |
13F
|
Company |
3.5%
|
4,315,102
|
$31,587,000 | — | 30 Sep 2020 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.9%
|
2,418,798
|
$17,706,000 | — | 30 Sep 2020 | |
| Novo Holdings A/S |
13F
|
Company |
1.7%
|
2,080,585
|
$15,230,000 | — | 30 Sep 2020 | |
| Boxer Capital, LLC |
13F
|
Company |
1.4%
|
1,777,194
|
$13,009,000 | — | 30 Sep 2020 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.4%
|
1,743,545
|
$12,764,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.58%
|
727,239
|
$5,323,000 | — | 30 Sep 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.46%
|
576,703
|
$4,221,000 | — | 30 Sep 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.31%
|
385,791
|
$2,824,000 | — | 30 Sep 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.25%
|
315,404
|
$2,309,000 | — | 30 Sep 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.25%
|
307,754
|
$2,253,000 | — | 30 Sep 2020 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.17%
|
213,310
|
$1,561,000 | — | 30 Sep 2020 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
198,708
|
$1,455,000 | — | 30 Sep 2020 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.08%
|
100,000
|
$732,000 | — | 30 Sep 2020 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.07%
|
85,155
|
$623,000 | — | 30 Sep 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.04%
|
51,200
|
$375,000 | — | 30 Sep 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
37,300
|
$273,000 | — | 30 Sep 2020 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
23,065
|
$169,000 | — | 30 Sep 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.02%
|
19,902
|
$146,000 | — | 30 Sep 2020 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
17,562
|
$129,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
16,560
|
$121,000 | — | 30 Sep 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.01%
|
15,100
|
$111,000 | — | 30 Sep 2020 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.01%
|
12,980
|
$95,014 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
12,795
|
$93,000 | — | 30 Sep 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
12,004
|
$88,000 | — | 30 Sep 2020 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
0.01%
|
11,990
|
$88,000 | — | 30 Sep 2020 | |
| SG3 Management, LLC |
13F
|
Company |
0%
|
5,000
|
$37,000 | — | 30 Sep 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,700
|
$13,000 | — | 30 Sep 2020 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
916
|
$7,000 | — | 30 Sep 2020 | |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. |
13F
|
Company |
0%
|
245
|
$2,000 | — | 30 Sep 2020 |
Institutional Holders of Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST) as of Q4 2020
As of 31 Dec 2020,
Milestone Pharmaceuticals Inc. - Common Shares, no par value per share (MIST) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,571,334 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, Novo Holdings A/S, ORBIMED ADVISORS LLC, BOXER CAPITAL, LLC, RA CAPITAL MANAGEMENT, L.P., Ikarian Capital, LLC, MORGAN STANLEY, SUVRETTA CAPITAL MANAGEMENT, LLC, MILLENNIUM MANAGEMENT LLC, and PURA VIDA INVESTMENTS, LLC.
This page lists
33
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
29
Q4 2020 holders
33
Holder diff
4
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.